J. Martin Carroll, Director at TherapeuticsMD, Inc. (TXMD), bought 10,000 shares at $6.11 ($61K) on 2015-05-08, disclosed to the SEC on 2015-05-12.
Open-market purchase of $61k TXMD by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| MNKKQ | SELL | 2021-03-16 | $17K | — | Filing → |
| MNK | BUY | 2017-11-13 | $204K | — | Filing → |
| ITEK | BUY | 2016-05-17 | $90K | — | Filing → |